Orthobiologics Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
Report ID: GMI2723
Orthobiologics Market size is projected to experience significant growth from 2018 to 2024.
Increasing number of orthopedic procedures owning to the rising geriatric population, accidents and obesity is driving the market growth. Increasing number people with orthopedic disease and musculoskeletal disease should result in rise in orthopedic surgeries, thus increase the demand for orthobiologics.
According to World Health Organization (WHO), fatal falls are the second-leading cause of accidental injury and factures worldwide in 2017.Rising cases of falls increase the chances of developing factures, thereby contribute to market growth.
High cost of procedures and post-surgery complications are the major challenges to orthobiologics market as these factors hinder the use of orthobiologics for the faster healing process of broken bones, injured muscles, and ligaments injuries. Moreover, stringent regulatory approval procedures for orthobiologics and limited number of clinical trials are affecting the market growth.
Viscosupplementation business segment held largest revenue share in 2017, on an account of high adoption of orthobiologics due to the wide range availability and unprecedented adoption in diseases such as Osteoarthritis and hip degenerative joint disease. Viscosupplementation exhibits the advantages such as better knee movement, pain reduction, less-invasive and fewer side effects. Bone Morphogenetic Proteins (BMPs) are effective in providing the fast recovery and reducing the pain among the patients.
Hospitals business accounted for major share due to high number of spinal and reconstructive surgeries performed in hospitals in comparison to ambulatory centers and clinics. With increasing number of specialty hospitals in developing countries will most likely perform advanced orthopedic procedures, resulting in slow but steady demand for various orthobiologics.
North America orthobiologics market held largest revenue share in 2017, owing to high number of orthopedic surgeries, musculoskeletal disease and obesity cases and availability of reimbursement policies or soft tissue healing and fusion enhancement products.
Asia Pacific orthobiologics market should witness lucrative growth during the forecasted period due to the rising healthcare expenditure and disposable income and physician awareness regarding Orthobiologics.
Some of the industry players include, Arthrex Inc., Globus Medical Inc, Medtronic Plc., Stryker Corporation, RTI Surgical Inc., K2M Group Holdings Inc., Kuros Biosciences Ltd., and others. Major players are undergoing the collaborations, acquisitions and agreement for the development of Orthobiologics. In February 2018, Bioventus had entered the LifeLink Tissue Bank, a division of LifeLink Foundation, Inc., for the development of next generation bone allograft solution for use in spine and trauma surgery.
Orthobiologics market by product type, 2013-2024 (USD Million)
- Demineralized Bone Matrix (DBM)
- Bone Morphogenetic Protein (BMP)
- Stem Cell Therapy
- Synthetic Bone Substitutes
Orthobiologics market by application, 2013-2024 (USD Million)
- Spinal Fusion
- Trauma Repair
- Reconstructive Surgery
- Fracture Recovery
- Osteoarthritis and Degenerative Arthritis
Orthobiologics market by end-use, 2013-2024 (USD Million)
- Hospitals and clinics
- Ambulatory surgery centers
- Dental Clinics
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.